You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
Potential applications<br />
Predictive tests of response to chemotherapy may be used<br />
in medical oncology to select patients with an increased<br />
likelihood to benefi t from therapy. The novel information<br />
on molecular mechanisms responsible for resistance to<br />
chemotherapy may lead to development of modulators of<br />
resistance. Both these advances may in turn lead to improved<br />
results of cancer chemotherapy. The development of tools<br />
to predict severe drug toxicity will lead to safer cancer<br />
chemotherapy.<br />
Coordinator<br />
Johan Hansson<br />
Karolinska Institutet<br />
Stockholm, Sweden<br />
Johan.Hansson@ki.se<br />
Partners<br />
Alan Spatz<br />
Institut Gustave Roussy<br />
Villejuif, France<br />
Guido Kroemer<br />
Institut National de la Santé<br />
et de la Recherche Médicale<br />
Paris, France<br />
Mariano Barbacid<br />
Fundación Centro Nacional de<br />
Investigaciones Oncológicas Carlos III<br />
Madrid, Spain<br />
Alexander Eggermont<br />
Erasmus Medical Centre Rotterdam<br />
Rotterdam, The Netherlands<br />
Marco Pierotti<br />
Istituto Nazionale per lo Studio<br />
e la Cura dei Tumori<br />
Milano, Italy<br />
Piet Borst<br />
Netherlands <strong>Cancer</strong> Institute<br />
Amsterdam, The Netherlands<br />
Curt Peterson<br />
Linköping University<br />
Linköping, Sweden<br />
Joakim Lundeberg<br />
Kungliga Tekniska Högskolan<br />
Stockholm, Sweden<br />
Joost van den Oord<br />
Katholieke Universiteit Leuven<br />
Leuven, Belgium<br />
Stefano Fais<br />
Istituto Superiore di Sanità<br />
Roma, Italy<br />
Manfred Schmitt<br />
Technical University of Munich<br />
München, Germany<br />
Mark Middleton<br />
University of Oxford<br />
Oxford, United Kingdom<br />
Geoff Margison<br />
University of Manchester<br />
Manchester, United Kingdom<br />
Anna Eidefors<br />
Magnetic Biosolutions AB<br />
Stockholm, Sweden<br />
Marie-Claire Beckers<br />
Eurogentec SA<br />
Seraing, Belgium<br />
Alexandre Passioukov<br />
European Organization for <strong>Research</strong><br />
and Treatment of <strong>Cancer</strong><br />
Brussels, Belgium<br />
Project number<br />
LSHC-CT-2006-037665<br />
EC contribution<br />
€ 8 710 300<br />
Duration<br />
60 months<br />
Starting date<br />
01/02/2007<br />
Instrument<br />
IP<br />
Project website<br />
www.chemores.org<br />
178 CANCER RESEARCH PROJECTS FUNDED UNDER THE SIXTH FRAMEWORK PROGRAMME
Change language